The Latest Breaking News from Quest

Shares of Quest Diagnostics (NASDAQ:DGX) are falling Tuesday after the medical laboratories company shared mixed earnings results.

Without one of the most influential RPGs ever, 'Final Fantasy Tactics' might not exist, and it's worth playing on its own merits even without that connection.

Quest Diagnostics Inc (NYSE:DGX) may be encountering what you might call a post-earnings digestion dance. Initially, DGX stock jumped higher, perhaps due to the algorithms and retail traders responding in unison to the better-than-expected results for the second quarter. But the next day, the security slipped, possibly as fund managers…

Quest Diagnostics Inc. (NYSE:DGX) delivered a robust second quarter in 2025, exceeding analyst expectations with strong sales and earnings growth, prompting an upward revision to its full-year guidance.

Johnny Vegas means business as he embarks on a surprise venture to turn his passion for collecting quirky items into a profit.

TNT Sports and Discovery+ are the only place to watch every minute live of the Tour, ITV to show live racing and highlights

Quest Diagnostics is expected to unveil its second-quarter results later this month, and analysts expect a single-digit growth in earnings.

While Quest Diagnostics has outshined the broader Nasdaq Composite over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Hands-on | Slaying slimes and becoming the dragon warrior in Dragon Quest 1 & 2 HD-2D Remake